Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2013 | 1 |
2016 | 1 |
2017 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.
N Engl J Med. 2023 Jul 20;389(3):205-214. doi: 10.1056/NEJMoa2303951. Epub 2023 May 21.
N Engl J Med. 2023.
PMID: 37272521
Clinical Trial.
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT, Thach C, Fogel R, Patalano F, Vogelmeier CF; FLAME Investigators.
Wedzicha JA, et al.
N Engl J Med. 2016 Jun 9;374(23):2222-34. doi: 10.1056/NEJMoa1516385. Epub 2016 May 15.
N Engl J Med. 2016.
PMID: 27181606
Free article.
Clinical Trial.
Item in Clipboard
Tiotropium Respimat inhaler and the risk of death in COPD.
Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators.
Wise RA, et al.
N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342. Epub 2013 Aug 30.
N Engl J Med. 2013.
PMID: 23992515
Free article.
Clinical Trial.
Item in Clipboard
Use of multidimensional data analysis for prediction of lung malignity.
Mrázová V, Mocák J, Varmusová E, Kavková D, Bednárová A.
Mrázová V, et al. Among authors: kavkova d.
J Pharm Biomed Anal. 2009 Sep 8;50(2):210-5. doi: 10.1016/j.jpba.2009.04.018. Epub 2009 Apr 23.
J Pharm Biomed Anal. 2009.
PMID: 19467816
Item in Clipboard
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Ferguson GT, FitzGerald JM, Bleecker ER, Laviolette M, Bernstein D, LaForce C, Mansfield L, Barker P, Wu Y, Jison M, Goldman M; BISE Study Investigators.
Ferguson GT, et al.
Lancet Respir Med. 2017 Jul;5(7):568-576. doi: 10.1016/S2213-2600(17)30190-X. Epub 2017 May 22.
Lancet Respir Med. 2017.
PMID: 28545978
Clinical Trial.
Item in Clipboard
Cite
Cite